INFLUENZA G1 mHA
- Generic Name
- INFLUENZA G1 mHA
A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults
Phase 1
Completed
- Conditions
- Influenza Prevention
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Janssen Vaccines & Prevention B.V.
- Target Recruit Count
- 170
- Registration Number
- NCT05901636
- Locations
- 🇺🇸
Floridian Clinical Research LLC, Miami Lakes, Florida, United States
🇺🇸CTI Clinical Trial and Consulting Services, Cincinnati, Ohio, United States
🇺🇸Johnson County Clin-Trials, Lenexa, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath